Transcriptomic Changes During the Replicative Senescence of Human Articular Chondrocytes

Area of Science:

• Biomedical Science
• Cell Biology
• Osteoarthritis Research

Background:

• Aging is a primary risk factor for osteoarthritis (OA), yet the precise molecular links remain elusive.
• Chondrocytes, critical for cartilage health, rarely divide in vivo but exhibit replicative senescence in vitro, providing a model for aging studies.
• Understanding chondrocyte aging is crucial for elucidating OA pathogenesis.

Purpose of the Study:

• To investigate the transcriptomic alterations in human articular chondrocytes during replicative senescence.
• To compare aging-related changes in normal chondrocytes versus those derived from osteoarthritis (OA) cartilage.
• To identify molecular pathways connecting chondrocyte aging and OA development.

Main Methods:

• Establishment and sub-culturing of human articular chondrocyte cultures from normal and OA cartilage to the Hayflick limit.
• Bulk RNA sequencing of early- and late-passage chondrocytes to analyze transcriptomic profiles.
• Differential gene expression analysis to identify changes in matrix synthesis, degradation, inflammation, and senescence-associated secretory phenotype (SASP).

Main Results:

• Early-passage OA chondrocytes exhibited senescent phenotypes, unlike normal chondrocytes.
• All chondrocyte cultures displayed senescence and lost cartilaginous pellet formation ability by replicative exhaustion.
• Significant differential gene expression was observed between early- and late-passage cells, and between normal and OA-derived cells, particularly in genes related to matrix metabolism, inflammation, and SASP.

Conclusions:

• Chondrocyte replicative senescence in vitro recapitulates aging-related molecular changes relevant to OA.
• Distinct transcriptomic profiles in OA chondrocytes suggest intrinsic aging differences contributing to disease.
• Further research into chondrocyte senescence mechanisms may offer novel therapeutic targets for osteoarthritis.